Markets News, Aug. 6, 2026: Dow’s Winning Streak Ends as Major Indexes Close Lower; Oil Rises as Investors Await Strait of Hormuz News
U.S. stocks fell Thursday as the Dow dropped over 450 points, ending a five-day winning streak. The Dow, S&P 500, and Nasdaq Composite closed down 0.9%, 0.2%, and 0.1%. Tech names including Honeywell Aerospace, AppLovin, Datadog, Western Digital, and Sandisk fell after quarterly results. Oil rose on hopes for U.S.-Iran Strait of Hormuz talks; WTI rose 3.7% to $78 and Brent 4.7% to $83.20.
How this was made
The 30-second read
Why it matters
Traders can use the discrete company catalysts (earnings/guidance misses for APP, DDOG, WDC, SNDK, HONA; FDA approval for MRNA; earnings beat for FOXA; lock-up mechanics for SPCX) to manage near-term volatility and relative-value positioning. Macro and geopolitical items (10-year yield, employment report, oil on Hormuz) may further amplify moves.
Market read
Broad U.S. indices closed lower, with several tech names selling off on earnings and guidance, while Moderna and Fox gained on regulatory approval and an earnings beat. Oil rose on potential Hormuz developments, and the next macro print is the July employment report.
What to watch
The article flags a major macro catalyst tomorrow (July employment report) and a geopolitical oil catalyst (Hormuz talks), which can dominate single-stock narratives intraday.
Background
This is a market wrap describing index declines, multiple tech earnings reactions, SpaceX’s first public-company results and lock-up release, Moderna’s FDA approval, and oil strength ahead of Strait of Hormuz news.
Ticker impact
Honeywell Aerospace shares retreated 23% after the company reported quarterly results, making the earnings reaction a direct trading catalyst.
Bearish bias for the next few sessions until management commentary/guidance is digested.
The article cites a very large percentage drop tied to quarterly results, but provides no specific guidance numbers to quantify magnitude beyond the move.
AppLovin stock fell 20% to a lowest level in over a year after revenue and third-quarter outlook disappointed analysts.
Potential for continued weakness or high volatility as investors reassess ad segment growth.
The text includes quantified EPS/revenue comparisons and a specific guidance range versus consensus, plus a price-target cut.
Datadog shares dropped 19% after quarterly results, indicating a material earnings reaction that can drive near-term positioning changes.
Downward pressure likely persists until follow-up disclosures clarify the drivers.
The article states the percentage decline but does not provide the underlying earnings/guidance figures for DDOG.
Western Digital shares fell 13% following quarterly results, signaling a sector-relevant read-through from storage demand expectations.
Bearish near-term bias, with volatility around any subsequent commentary.
The article provides the size of the move but no specific WDC guidance metrics.
Sandisk shares declined 7% after quarterly results, making the earnings print a direct catalyst for the stock.
Limited but negative near-term drift unless new details emerge.
The article only gives the percentage move without the specific earnings/guidance drivers.
Microsoft was the biggest Magnificent Seven mover, up 2.5% on the day despite other tech weakness after quarterly results.
Mild bullish bias versus the broader tech complex in the near term.
The article notes the move size but does not provide Microsoft-specific earnings or guidance details.
SpaceX shares rebounded 6% after plunging nearly 14% the prior session, tied to digestion of its first public-company results and lock-up expiration.
Choppy trading with potential sell-pressure around ongoing unlocks, offset by retail demand.
The article provides concrete catalysts (first results, lock-up release of ~911M shares) but no forward guidance numbers.
Moderna shares rose in premarket after FDA approval of mFLUSIVA, a new mRNA-based flu vaccine.
Bullish near-term reaction with follow-through dependent on launch uptake and pricing.
The article states FDA approval and availability timing, but does not quantify expected revenue or uptake.
Market effects
Tech earnings disappointments (HONA/APP/DDOG/WDC/SNDK) reinforce a risk-off stance toward growth and ad-tech/storage cycle expectations, while energy strength is supportive.
Primarily U.S. equity sentiment, with rate sensitivity signaled by the 10-year yield rising to ~4.68%.
Oil up on Strait of Hormuz reopening expectations can spill over into energy equities and inflation expectations.
Counterpoint
Some of the tech weakness may be company-specific, so index-level selling could overstate the broader earnings risk if guidance dispersion is large.
Key entities
- companyAppLovin
Ad-tech firm with a quantified revenue/outlook miss and a lowered analyst price target.
- companyModerna
FDA-approved mRNA flu vaccine mFLUSIVA, a discrete regulatory catalyst.
- companySpaceX
First public-company results digestion plus lock-up expiration releasing ~911M shares.
- companyFox Corporation
World Cup-driven advertising surge supporting a better-than-expected quarter.
- government_agencyU.S. Bureau of Labor Statistics
Scheduled release of the July employment report referenced as the next major macro driver.
